ABBOTT PARK, Ill., March 31, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for over-the-counter, non ...

With an unprecedented surge in COVID-19 cases due to the spread of the more contagious omicron variant following the holiday season, coronavirus testing is becoming crucial for people looking to see ...

Rapid antigen testing using a nasal swab with the BinaxNOW test was able to detect the Omicron variant at an urban community testing site, whereas other swabbing routes did not perform as well, ...

Test to be available for $23.99 without a prescription, to allow for greater access to testing, and together with vaccines, help to restore a sense of safety in everyday settings where people gather ...

The U.S.'s first over-the-counter rapid COVID-19 test kits—Abbott's BinaxNOW Self Test and Ellume's COVID-19 Home Test—are being sold at Walmart, CVS and Walgreens. Both rapid antigen tests, which are ...

The test has been authorized for home use to collect nasal swab samples from individuals 2 years of age and older. The Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) ...

The Abbott BinaxNOW, a rapid antigen test, identified 95 percent of people carrying high levels of the virus, researchers found. By Emily Anthes The Abbott BinaxNOW, a widely used at-home coronavirus ...

SAN FRANCISCO (KGO) -- With more and more people testing themselves for coronavirus at home, some have taken to swabbing their throats, even though the FDA says you shouldn't. After a suspected ...

FDA Emergency Use Authorization permits asymptomatic, non-prescription, over-the-counter self use for people with or without symptoms The BinaxNOW COVID-19 Self Test is identical to the ...

This test is authorized for non-prescription home use with self-collected direct anterior nasal (nares) swab samples from individuals aged 15 years or older or adult collected anterior nasal swab ...